NRC · Nrc Health · Metrics
$22.94
+1.19 (+5.47%)
At close · Oct 28
Return incl. dividend (before tax)
Q4 2025 earnings call transcript
Market Cap
$481.10M
Shares
22.12M
Volume · Oct 28
147.28K
Avg daily vol (3M)
116.54K
NRC metrics
110 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$21.75
Market cap
$481.10M
Price action
20 metricsPrice change (1W)
+5.1%
Price change (30D)
+8.4%
Price change (3M)
-2.6%
Price change (6M)
+29.2%
Price change (YTD)
+15.9%
Price change (1Y)
+90.5%
Trailing year
Price change (5Y)
-49.1%
52-week high
$22.77
52-week low
$11.42
Change from 52-week high
-4.5%
Change from 52-week low
+90.5%
Annualized volatility
58.3%
Annualized volatility (3M)
56.6%
Beta
0.5
RSI (14D)
55.9
Price vs SMA 50
+3.0%
Price vs SMA 200
+13.7%
Avg volume (3M)
116,535
Relative volume
0.9
Average dollar volume
$2.44M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
22.12M
Valuation
12 metricsP / E (TTM)
0.4
Trailing earnings · reciprocal yield 228.7%
PEG ratio
0.0
EV / revenue
4.2×
reciprocal yield 24.0%
EV / EBITDA
25.0×
reciprocal yield 4.0%
EV / EBIT
39.6×
reciprocal yield 2.5%
P / sales
3.5×
reciprocal yield 28.2%
P / book
75.8
reciprocal yield 1.3%
FCF yield
4.4%
TTM · current market cap
Buyback yield
3.8%
P / FCF
22.9
reciprocal yield 4.4%
P / operating cash flow
16.8
reciprocal yield 5.9%
Earnings yield
1.2%
Historical valuation
8 metricsP / E historical average (3Y)
29.6×
reciprocal yield 3.4%
P / E historical average (5Y)
29.3×
reciprocal yield 3.4%
EV / revenue historical average (3Y)
4.1×
reciprocal yield 24.2%
EV / revenue historical average (5Y)
5.2×
reciprocal yield 19.2%
EV / EBIT historical average (3Y)
19.1×
reciprocal yield 5.2%
EV / EBIT historical average (5Y)
20.1×
reciprocal yield 5.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
2.9%
Trailing 12 months
Payout ratio
216.9%
Shareholder yield
6.4%
Dividend / share (TTM)
$0.64
Dividend growth YoY
+33.3%
Dividend growth streak
1
Last ex-dividend
2026-09-25
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-27
Profitability
9 metricsGross margin
—
Operating margin
10.5%
Trailing 12 months
Net margin
4.2%
Gross profit (TTM)
—
Operating profit (TTM)
$14.74M
Net income (TTM)
$5.86M
Trailing 12 months
Diluted EPS (TTM)
$49.75
FCF margin
15.5%
Effective tax rate
37.6%
Growth
11 metricsRevenue growth YoY
+4.0%
Year over year
Net income growth YoY
-53.2%
Revenue (TTM)
$140.00M
Trailing 12 months
EPS growth YoY
+4,707.7%
Shares change YoY
-2.9%
Year over year · fewer shares
Revenue CAGR (3Y)
-3.2%
Revenue CAGR (5Y)
+0.6%
EPS CAGR (3Y)
+240.2%
EPS CAGR (5Y)
+103.0%
FCF CAGR (3Y)
-15.9%
FCF CAGR (5Y)
-15.5%
Quality
14 metricsReturn on equity
89.4%
Return on assets
4.3%
Debt / equity
13.7
Current ratio
0.7
EBITDA (TTM)
$23.37M
Free cash flow (TTM)
$21.64M
Quick ratio
0.7
Interest coverage
2.7
Net debt / EBITDA
3.7
Return on invested capital
9.9%
Trailing 12 months
Net cash
−$86.70M
Latest balance sheet
Cash & equivalents
$3.33M
Total assets
$136.15M
Total debt
$90.03M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$29.51M
Capital expenditures (TTM)
$7.87M
R&D (TTM)
—
SG&A (TTM)
$63.08M
Stock compensation (TTM)
$11.81M
R&D / revenue
—
Stock compensation / revenue
8.4%
Ownership (13F)
9 metrics13F filers
124
13F filer change QoQ
+2
Institutional ownership
48.7%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
9.7%
Private-fund adviser ownership
9.1%
Active holders' share change QoQ
+0.2%
Holder tenure
18.7
Price vs estimated holder cost
-12.3%
Ownership (registered funds)
1 metricsIndex-fund ownership
9.4%
Short interest
3 metricsShort interest
3.3%
Latest settlement · 8.1 days to cover
Days to cover
8.1d
Short-squeeze score
81 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—